High-flow nasal cannula versus home mechanical ventilation for COPD patients with persistent high carbon dioxide after an exacerbation
Official title: Respiratory Strategies in COPD Patients With Persistent Hypercapnia Following Exacerbation: A Multicenter, Non-inferiority, Randomized, Crossover Study
Run by IRCCS Azienda Ospedaliero-Universitaria di Bologna · NCT07065799 · Data updated 2026-11-12
This study tests whether using high-flow nasal cannula plus standard oxygen can lower CO2 as well as home mechanical ventilation plus standard oxygen in people with COPD who still have high CO2 after a severe flare.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 90 Years |
| Sex | All |
| Enrollment | 31 (estimated) |
| Sponsor | IRCCS Azienda Ospedaliero-Universitaria di Bologna Academic / other |
| Locations | 5 sites (Arezzo and 4 other locations) |
| Status | Recruiting |
| Started | June 30, 2024 |
| Main results expected | December 2027 |
| Study ends | January 2028 |
| Registry record updated | July 15, 2025 |
| Trial ID | NCT07065799 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults with COPD who remain hypercapnic (PaCO2 >53 mmHg) 2–4 weeks after a hypercapnic exacerbation requiring noninvasive ventilation, with pH >7.35 and chronic hypoxemia meeting the protocol thresholds, are the intended participants.
✕Probably not a fit
Patients with BMI >30 kg/m2, clinically significant obstructive sleep apnea, neuromuscular or chest wall disease, those already on home NIV/CPAP, or those who required intubation during the exacerbation are unlikely to benefit from this comparison.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This multicenter, randomized crossover trial enrolls patients with COPD and persistent hypercapnia after a severe exacerbation and compares two home respiratory supports: high‑flow nasal cannula (NHF) plus standard oxygen and home mechanical ventilation (HMV) plus standard oxygen. Each participant receives both treatments for three months in randomized order with a seven‑day washout, so each patient serves as their own control. The primary outcome is change in arterial PaCO2 to test non‑inferiority of NHF versus HMV. Secondary outcomes include safety, tolerability, and clinical events over the total 25‑week treatment period.
Why it matters
Potential benefit: If successful, the study could provide a simpler, better‑tolerated home breathing option that lowers CO2 similarly to home mechanical ventilation.
How similar studies have gone: Home mechanical ventilation is an established treatment for chronic hypercapnia, while high‑flow nasal cannula has shown promising PaCO2 reductions in smaller studies, but direct non‑inferiority comparisons versus HMV are still limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥18 years * Acquisition of informed consent form * Patients with COPD * Persistent hypercapnia (PaCO2 \>53 mmHg) 2-4 weeks after an acute hypercapnic exacerbation of COPD requiring NIV. * pH value \>7.35. * Chronic hypoxemia (PaO2 \<55mmHg or \<60mmHg if at least one of the following criteria is present: polycythemia, pulmonary hypertension or Chronic Pulmonary Heart Disease, \>30% of sleep time with SpO2 \< 90% measured with a pulse oximeter) Exclusion Criteria: * BMI \>30 kg/m2 * Clinically significant obstructive sleep apnea syndrome (patients in whom there was a clinical suspicion of OSA syndrome based on clinical review or overnight oximetry will go further testing with limited respiratory polygraphy) * Neuromuscular or chest wall diseases * Need for intubation and invasive mechanical ventilation during exacerbation * Use of home non-invasive mechanical ventilation or CPAP * Contraindications for NIV * Presence of cognitive impairment that would prevent informed consent into the trial * Patients with active and unstable coronary artery syndrome * Patients suffering from malignancies
Where it's running
-
Ospedale S Donato
Arezzo, Italy Recruiting -
Bolzano Hospital
Bolzano, Italy Recruiting -
Azienda Ospedaliera Universitaria Policlinico "G. Rodolico-Sn Marco"
Catania, Italy Recruiting -
ICS Maugeri Spa Società Benefit IRCCS
Pavia, Italy Recruiting -
Azienda Unità Sanitaria Locale
Piacenza, Italy Recruiting
Study contacts
- Principal investigator: Lara Pisani, Prof.ssa — University of Bologna
- Study coordinator: Lara Pisani, Prof.ssa
- Email: lara.pisani@unibo.it
- Phone: 0512143257
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Does nighttime hypoventilation predict long-term benefit from non-invasive ventilation in people with hypercapnic COPD?
This project tests whether nighttime hypoventilation can identify people with COPD and high CO2 who will have larger drops in arterial CO2 after 6 and 12 months on non-invasive ventilation.
-
Comparing new nasal interface with standard cannula for COPD patients
This study is testing a new type of nasal breathing device against a standard one to see which helps people with COPD feel better during a flare-up.
-
AERO-007: a inhaled LABA+LAMA combination for COPD through a nebulizer
This study tests whether a nebulized LABA+LAMA combination can improve lung function in adults with COPD.
-
Cognitive load and inhaler technique in COPD
This study tests whether adding a short memory task while using an inhaler makes COPD patients more likely to misuse their inhaler.
-
Balance training after pulmonary rehab for COPD to help steadiness and reduce falls
A COPD-focused balance training program called Sport4Steadiness is being tested to see if people with COPD will accept it and if the study processes work well.
-
Continuous vs High-Intensity Interval Exercise in COPD
This study tests whether continuous versus high-intensity interval exercise affects cerebral oxygenation in people with COPD.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.